Page values for "Abecma"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 853,973 |
| _pageName | Page | Abecma |
| _pageTitle | String | Abecma |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Abecma |
| Short_definition | String | Abecma (uh-BEK-moo) drug used to treat adults with multiple myeloma who have relapsed (returned) or failed to improve after treatment with at least four other cancer therapies, including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulating drug. It is also being studied |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |